Chemoinformaics analysis of 9-OCTADECEN-1-OL, (9Z)-
| Molecular Weight | 268.485 | nRot | 15 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 1 |
| Exact Molecular Weight | 268.277 | nRing | 0 |
| Solubility: LogS | -6.544 | nHRing | 0 |
| Solubility: LogP | 7.371 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.8665 |
| nHD | 1 | BPOL | 36.1155 |
| QED | 0.284 |
| Synth | 2.067 |
| Natural Product Likeliness | 0.945 |
| NR-PPAR-gamma | 0.462 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.022 |
| HIA | 0.005 |
| CACO-2 | -4.664 |
| MDCK | 0.0000146 |
| BBB | 0.103 |
| PPB | 0.9731 |
| VDSS | 3.433 |
| FU | 0.0194088 |
| CYP1A2-inh | 0.516 |
| CYP1A2-sub | 0.184 |
| CYP2c19-inh | 0.355 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.185 |
| CYP2c9-sub | 0.947 |
| CYP2d6-inh | 0.039 |
| CYP2d6-sub | 0.075 |
| CYP3a4-inh | 0.25 |
| CYP3a4-sub | 0.037 |
| CL | 6.095 |
| T12 | 0.161 |
| hERG | 0.169 |
| Ames | 0.005 |
| ROA | 0.01 |
| SkinSen | 0.966 |
| Carcinogencity | 0.052 |
| EI | 0.931 |
| Respiratory | 0.082 |
| NR-Aromatase | 0.387 |
| Antiviral | Yes |
| Prediction | 0.619854 |